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Thyroid Disease: Diagnosis and 
Management of Hyperthyroidism 
Dr Noel Caruana 
This short rcview article aims to pmvide L1pdated information 
on the diagnosis and management ofhyperthymidism. 
A second article will focus on the management of hypothymidism. 
The most appropriate management of hyperthyroidism 
depends to a large extent on the proper diagnosis based on 
recognition of symptoms and signs of the disease followed by 
detem1ination of the underlying pathology. Graves disease is the 
most common underlying pathology followed by thyroiditis, 
multinodular goitre, toxic adenomas and iatrogenic causes. Graves 
disease, toxic adenoma and toxic multinodular goitre may be 
treated by surgery, antithyroid drugs or radioactive iodine. 
Treatment for hyperthyroidism caused by thyroiditis is usually 
symptomatic as the condition is usually transient. Treatment is 
not always straightforward however, as in such cases of associated 
ophthalmopathy in Graves disease and in patients who are 
pregnan tor breastfeeding. I t is very importan t to plan appropriate 
treatment with the patient. 
Thyrotoxicosis or clinical hyperthyroidism is due to the effects 
of surplus thyroid hormone and can be caused by different 
Signs and SymptOillS Older Patients Younger patients 
<50 years % 
Tachycardia 
Fatigue 
Weight loss 
Goitre 
Tremor 
Apathy 
Anial fibrillation 
Anorexia 
Nervousness 
Hyperactive reflexes 
Depression 
Increased sweating 
Polydipsia 
Heat il1tolerance 
Increased appetite 
> 70 years % 
7l 
56 
50 
50 
44 
41 
35 
32 
31 
28 
24 
24 
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Tablci : 1I1cidcl1cc of Signs and Symptoms ofhyperthyroidism 
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disorders. Prevalence of hyperthyroid disease based on 
community studies has been estimated at 2% in females and 
0.2% in males Thus a family practice of 2500 patients is 
expected to have a prevalence of ten thyroid cases with one new 
case annually. The clinical diagnosis of an over active thyroid can 
be difficult as the initial clinical deviations from normal can be 
minima!. 
Symptoms are caused by the thyroid hormone's stimulation 
of the enzymatic catabolic activity and increased sensitivity to 
cathecholamines. Symptoms are usual1y more flOlid in younger 
patients, elderly patients may present with only cardiovascular 
signs such as atrial fibrillation and tachycardia, or with 
unexplained weight loss. Common symptoms and signs are listed 
in Table 1 ,,~th an emphasis on the differences in presentation 
between old and young patients. 
Tests for thyroid disorders 
Thyroid function tests 
With the highly sensitive TSH assays it is now possible to 
distinguish suppressed TSH levels in hyperthyroid states from 
low but normal-10w TSH levels in the euthyroid state. lt should 
however be noted that tests on their own are not foolproof and 
should be interpreted vvith the clinical situation in mind. Serum 
tri-iodothyronine (13) and free thyroxine (14) measurements can 
be useful in suspected T4 toxicosis where serum T41evels may 
be nom1al. 13 and T 41evels are also useful for monitoring patients 
on treatment for thyroid dysfunction . 
Thyroid autoantibodies 
Raised antimicrosomal and antithyroid peroxidase 
antibodies are indicative of Hashimoto's autoimmune thyroiditis . 
Antithyroglobulin and antimicrosomal antibodies are 
characteristically elevated in Graves' disease. Thyroid stimulating 
antibody (Thyroid-stimulating hormone receptor antibodies) 
levels are also used to monitor the effects of treatment of Graves' 
disease with antithyroid drugs. 
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Thyroid ultrasound 
A thyroid ultrasound is usually more sensitive at detecting 
thyroid nodules. With ultrasound it is easier to diagnose a 
multinodular goitre which was clinically thought to be a solitary 
nodule (other nodules not being palpable clinically). This finding 
has clinical and prognostic significance as a multinodular goitre 
is said to be less likel)' to be malignant than a single nodule. It 
can also differentiate a solid mass from a cystic one. Also, high 
resolution Ultrasound is better than CT in assessing glandular 
texture. 
CT sean 
This examination is particularly useful to determine if there 
is any compression of the trachea and if there is any retro stemal 
and retrotracheal extension as sometimes happens in Hashimoto 
thyroiditis. It will also show the presence of a calcified adenoma 
or cyst. 
Fine needle Biopsy 
This is the most cost-effective test in the diagnosis of thl'roid 
nodules, when the nature of the goitre is stil! in doubt. It is also 
the best wal' to assess a nodule for malignancy. Multiple biopsies 
may be taken under local anaesthetic, but it is to be remembered 
that with small biopsl' specimens, false negative result is a 
possibility. 
Cause 
Graves disease thyroid 
stimulating ab 
Pathophysiology 
Increased stimulation of gland 
Aet iology (see Table 2) 
Graves Disease 
This is the most common cause of hyperthyroidism, and 
accounts for up to 75% of all cases . 
It is classified as an autoimmune disease caused byan anti 
TSH receptor antibodl' which stimulates the gland to synthesize 
and secrete more thl'roxine. There is an increased prevalence of 
HLA-DR3 which thus appears to occur in a geneticalll' 
predisposed population, and mal' be associated with other 
autoimmune diseases. An infiltrative ophthalmopathl' 
accompanies Graves' disease in 50% of cases. 4 
Toxie Multinodular Goitre 
This usualll' has a more insidious onset, and typicalll' occurs 
in patients over the age of 50 years who have a longstanding 
historl' of goitre. The nodules are usualll' tender. 
Toxie Adenoma 
These are usualll' found in younger individuals especially in 
iodine deficient areas. There is a single autonomously functioning 
nodule which is not tender to palpation. 
Thyroiditis 
Typically is abrupt in onset and usually follows a vi ral 
infection. The symptoms may be quite severe and are due to 
Gland size Nodularity 
Increased None 
Toxic multinodular goitre Autonomous honnone production lncreased Multiple nodules " 
Subacute thyroiditis 
Toxic adenoma 
Lymphocytic thyroiditis 
Iodine-induced (iodide, 
amiodarone contrast media) 
Functioning pituitary 
adenoma (TSH; trophoblastic 
tumour hCG 
Factitial hyperthyroidism 
Metastatic thyroid cancer 
' Tencln gla nd 
Table 2: Aetiology 
\I altcsc Famih- Dacto r 'l-llhb (:l, . F,l'''''''' 
Leakage of hormone from gland Increased None* 
Autonomous hormone production Decreased Single nodule 
Leakage of hormone from gland Increased None 
Substance causing stimulation of gland Increased Multiple or None 
lncreased glandular stimulation lncreased None 
Exogenous hormone intake Decreased None 
Extraglandular hormone production Decreased None 
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hormone leaking from an inflamed gland. Symptoms usually 
resolve within a few months. 
Postpartum thyroiditis can occur in up to 10% of women in 
the first six months after delivery The hyperthyroid state may 
lead to a transient hypothyroid state before resolution 5 
Tumours 
It is indeed quite rare to have a tumour as a cause of 
hyperthyroidism. Such tumours include: metastatic thyroid cancer, 
ovarian tumours that produce thyroid hormones and trophoblastic 
tumours that produce human chorionic gonadotrophin which 
activate TSH receptors. Pituitary tumours also produce TSH. 
I nvestigation 
The initial most significam test to be done in a patient with 
signs and symptoms of hyperthyroidism is TSH estimation. A 
very low TSH level is diagnostic ofhyperthyroidism. An algorithm 
for investigating suspected hyperthyroidism is illustrated in figure 1. 
An elevated TSH warrants the estimation of freeT4 levels, which 
if high, indicate secondary hyperthyroidism and necessitate 
pituitary gland imaging. 
characteristically elevated in Graves disease. Thyroid stimulating 
antibody levels are also used to monitor the effects of treatment 
of Graves disease with antithyroid drugs. 
Management of hyperthyroidism 
Main principles of management: 
1. Establish precisely the cause for the hyperthyroidism before 
starting treatment (Figure 1) 
2. Educate your patient and emphasise the need for lifelong 
monitoring due to possibility of relapse 
3. Monitor for cardiovascular complications and osteoporosis 
The aim of treatment is to correct the hypermetabolic - state 
with the least possible side effects including hypothyroidism. 
The main treatment options are; antithyroid drugs, radioiodine 
and surgery. The choice depends on the patient's age, size of 
goitre, co morbidity and patient's desires. 
Anti-thyroid drugs 
This class of drugs works by interfering with the organification 
of iodine thus suppressing thyroxine levels. Carbimazole is used 
locally with a dose of 10-45 mg daily (Methimazole and 
propylthiouracil are two agents used in the United States) Relapse 
Antibody studies can occurin up to 50% of patients hence the importance of regular 
Raised antimicrosomal and antithyroid peroxidase follow-up. A recent RCT6 showed that patients with a large goitre, 
antibodies are indicative of Hashimoto's autoimmune thyroiditis. who smoked and had high thyroid-stimulating antibody levels at 
Antithyroglobulin and antimicrosomal an tibodies are end of treatment had higher relapse rates. 
LowTSH 
( High 14 
Measure 13 H Normal14 Normal13 
Primary hyperthyroidism I J 
Measure 13 Antibody studies 
High 13 
Thyroid uptake 
Radionucleotide scan 
Resolving 13 toxicosis 
hyperthyroidism ( 
l High uptake 
Low uptake 1 ) 
Exogenous hormone l. Graves diffuse uptake 
(Low thyroglobulin level) 2. Nodular Toxic multi nodular 
OR Thyroiditis (high thyroglobulin) OR toxic Adeneoma (hot spot) 
Figure 1: AIgorithl11 for investigating low TSH level in suspected l1yperthymidisl11 
J 
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Carbimazole is usually the drug of choice( Propylthiouracil 
100-200mg daily is used in pregnancy) , with a starting dose of 
10mg daily and can be given in combination with Propranolol 
10-40 mg 6-8 hourly. 7 The beta blocker is tapered down over 
a period of one to two months, and the carbimazole is titrated 
according to clinical response and monthly free T4 towards a 
normal T} and T , level. lt is important to note that the TSH 
levels may remain very low despite the patient having retumed 
to the normal state with treatment, and should not be used to 
gauge treatment. After one year of treatment, if the anti-TSH-
receptor antibodies are not detectable one can stop the anti-
thyroid treatment 4 The patient should be monitored every 
three momhs during the first year as relapse on stopping 
treatment is common. Once a relapse occurs it is usually 
recommended that radioactive iodine (illI) therapy or subtotaV 
total thyroidectomy be considered. The risk of agranulocytosis 
is the most serious complication of antithyroid treatment and 
patiems should be warned to stop treatment if they develop 
sudden fever or sore throat. Arthralgia and polyarticular arthritis 
may also occur, although to a minor extent. 
Surgery 
A subtotal thyroidectomy is the most common performed 
procedure; it preserves some thyroid tissue and hence reduces 
the risk of hypothyroidism. Total thyroidectomy is reserved for 
very large goitres and those with very severe symptoms, in 
whom recurrences are !ikely. This procedure however carries a 
high risk of hyper parathyroidism and laryngeal nerve damage8 
Radioactive therapy 
Radioactive iodine is gradually replacing surgery, and in 
the United States it is the preferred mode of treatment for 
Graves' disease and toxic nodular goitre. There is stil! much 
debate about the treatment regime of radioiodine. Gland-
specific dosage , based on the estimated weight of the thyroid 
gland, allows a lower dosage to be given and is associated with 
lower incidence of hypothyroidism, but may have a higher 
recurrence rate. There is stil! reluctance to use radio therapy in 
women of child bearing age because of the possibility of cancer 
of thyroid, genetic damage to offspring and leukaemia, however 
long term study of these patients has failed to support these 
fears9 Patients with toxic adenomas and toxic nodular goitre 
are more radio resistant and need higher dose regimen to 
achieve remission. lt is important to note that up to 15 % of 
patients treated with radioiodine, may develop Graves' 
ophthalmopathy. Opthalmopathy may be controlled or its 
incidence reduced with the use of 40 to 80mg of Prednisolone 
dailyI° 
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Precautions on radioactivity hazards. Most radioactive 
sodium iodide is excreted via saliva, urine and feaces within 48 
hours of receiving the dose. Close contact with persons should 
be avoided for up to three days, especially children and pregnant 
women. lt is also recommended to double flush toilet and repeat 
hand washing for 12 weeks 9 
Outcome and follow-up 
Patients receiving appropriate management have a good 
prognosis. Some extra-thyroid manifestations of the disease , 
notably ophthalmopathy, and cardiac complications are resistant 
to all forms treatment. In view of increased morbidity, patients 
who have been treated for hyperthyroidism should be screened 
annually, with special emphasis to atherosclerosis, osteoporosis, 
diabetes and insidious hypothyroidism 11 . 
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